COVID-19 mAb development pipeline
Abwiz Bio's Response to COVID-19
Abwiz Bio is open for business during the COVID-19 outbreak and is actively developing next-generation SARS-CoV-2 monoclonal antibodies for immediate diagnostic use.
Our antibody reagents are available for purchase and immediate preparation/shipping under strict clean and sterile conditions. We are continuing to support basic and translational research with our academic and corporate partners during this time, and our revolutionary rabbit mAb development platform and affinity maturation services are ready to advance your goals.
Learn more about all that we are doing, and get updates on our current progress developing SARS-CoV-2 mAbs.
Abwiz Bio has been awarded a STTR grant from the NIH! We will develop an antibody to treat rheumatoid arthritis.